In addition, syringin has been reported to exert cardioprotective effects in diabetic cardiomyopathy through the interaction of TLR4/NF-κB/NLRP3 and PGC1a/SIRT3 pathways [37]. Here, PPARGC1A is linked to diabetic cardiomyopathy.